Wong, M. K. K., Sacco, J. J., Robert, C., Michels, J., Bowles, T. L., In, G. K., … Milhem, M. M. (2024). Efficacy and safety of RP1 combined with nivolumab in patients with anti-PD-1-failed melanoma from the IGNYTE clinical trial. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).

Wong, Michael K. K., Joseph J. Sacco, Caroline Robert, Judith Michels, Tawnya Lynn Bowles, Gino Kim In, Katy K. Tsai, et al. “Efficacy and safety of RP1 combined with nivolumab in patients with anti-PD-1-failed melanoma from the IGNYTE clinical trial.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.

Wong MKK, Sacco JJ, Robert C, Michels J, Bowles TL, In GK, et al. Efficacy and safety of RP1 combined with nivolumab in patients with anti-PD-1-failed melanoma from the IGNYTE clinical trial. In: JOURNAL OF CLINICAL ONCOLOGY. 2024.

Wong, Michael K. K., et al. “Efficacy and safety of RP1 combined with nivolumab in patients with anti-PD-1-failed melanoma from the IGNYTE clinical trial.” JOURNAL OF CLINICAL ONCOLOGY, vol. 42, no. 16, 2024.

Wong MKK, Sacco JJ, Robert C, Michels J, Bowles TL, In GK, Tsai KK, Lebbe C, Gaudy-Marqueste C, Couselo EM, Middleton MR, Samson A, Schadendorf D, Beasley G, Niu J, Chmielowski B, Wise-Draper TM, Zhu J, Viana M, Milhem MM. Efficacy and safety of RP1 combined with nivolumab in patients with anti-PD-1-failed melanoma from the IGNYTE clinical trial. JOURNAL OF CLINICAL ONCOLOGY. 2024.